21st Aug 2018 7:00 am |
RNS |
PDMR dealings |
20th Aug 2018 7:00 am |
RNS |
PDMR Dealing |
17th Aug 2018 7:00 am |
RNS |
PDMR Dealing |
16th Aug 2018 9:00 am |
RNS |
Filing of Investigational New Drug application |
27th Jul 2018 7:00 am |
RNS |
US Registration Statement for Proposed Offering |
25th Jun 2018 10:49 am |
RNS |
Result of AGM |
7th Jun 2018 7:01 am |
RNS |
Appointment of Broker |
7th Jun 2018 7:00 am |
RNS |
Final Results |
1st Jun 2018 7:00 am |
RNS |
Notice of AGM |
23rd May 2018 4:40 pm |
RNS |
Second Price Monitoring Extn |
23rd May 2018 4:35 pm |
RNS |
Price Monitoring Extension |
16th May 2018 7:00 am |
RNS |
Milciclib Phase 2a Trial - Tolerability Update |
1st May 2018 3:00 pm |
RNS |
Grant of Options - Director Dealing |
27th Apr 2018 7:00 am |
RNS |
Issue of Equity |
19th Apr 2018 7:00 am |
RNS |
Subscription |
16th Apr 2018 7:25 am |
RNS |
License Agreement |
9th Apr 2018 8:25 am |
RNS |
Presentation at ASCO 3 June 2018 |
5th Apr 2018 7:00 am |
RNS |
Appointment of Broker |
4th Apr 2018 7:00 am |
RNS |
Appointment of Director |
5th Mar 2018 7:00 am |
RNS |
Placing to raise £600,000 and issue of equity |
2nd Mar 2018 12:09 pm |
RNS |
Statement re broker |
22nd Jan 2018 7:00 am |
RNS |
Placing |
16th Jan 2018 7:00 am |
RNS |
Placing |
15th Dec 2017 7:00 am |
RNS |
Placing and Issue of Equity |
8th Dec 2017 7:00 am |
RNS |
Milciclib Phase 2a Trial Update |
27th Nov 2017 7:00 am |
RNS |
Placing |
23rd Nov 2017 7:00 am |
RNS |
Phase II Clinical Trial Update |
20th Nov 2017 7:00 am |
RNS |
Subscription |
29th Sep 2017 7:00 am |
RNS |
Interim Results for Six Months Ended 30 June 2017 |
6th Sep 2017 7:00 am |
RNS |
A Proprietary Oral Formulation of Foralumab |
31st Aug 2017 11:07 am |
RNS |
Grant of options - Director's dealing |
16th Aug 2017 7:00 am |
RNS |
Conversion of outstanding loan notes |
28th Jul 2017 7:00 am |
RNS |
Publication of Research Article on Foralumab |
19th Jul 2017 7:00 am |
RNS |
Initiation of a Phase IIa Clinical Trial |
12th Jul 2017 7:00 am |
RNS |
Proposed changes to CLNs and Warrant Terms |
29th Jun 2017 11:21 am |
RNS |
Result of AGM |
12th Jun 2017 7:00 am |
RNS |
Appointment of Dr Kunwar Shailubhai as CEO |
8th Jun 2017 10:02 am |
RNS |
NOTIFICATION OF MAJOR INTEREST IN SHARES |
8th Jun 2017 8:14 am |
RNS |
Bcl-3 pre-clinical update and Director's dealing |
1st Jun 2017 7:00 am |
RNS |
2016 Annual Report and Accounts and notice of AGM |